Tinnitus – Cannabis Research

Tinnitus Research Dashboard


Primary Studies


Related Studies


Total Studies

Clinical Studies


Clinical Meta-analyses


Double-blind human trials


Clinical human trials

Pre-Clinical Studies




Animal studies


Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 13 studies associated with Tinnitus.

Here is a small sampling of Tinnitus studies by title:

Components of the Tinnitus Research Dashboard

  • Dosing information available for Tinnitus
  • Chemotype guidance for treating Tinnitus with cannabis
  • Synopsis of cannabis research for Tinnitus
  • Individual study details for Tinnitus

Ready to become a subscriber? Go to our PRICING page.

Select New Condition

Search By Keyword

Filter Condition

Members can filter by the following criteria:

  • Study Type
  • Chemotype
  • Cannabinoids & Endocannabinoids
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Tinnitus

Description of Tinnitus

Tinnitus is defined by the auditory experience of sounds that others can’t hear. It is often described as a high-pitched sound reminiscent of hissing or ringing, and the sound experience may be subtle or significant. It may involve a one-sided experience or a bilateral one it can be constant or intermittent. Subjective tinnitus indicates an experience only the patient can hear while objective tinnitus refers to an auditory experience that can be heard by the examining physician by using a stethoscope for example. Depending on the person with tinnitus is can be a mild annoyance or a severe disability causing additional problems such as a lack of concentration or depression for instance. Causes include earwax, trauma or disease of the ear, other conditions such as MS, or psychological stress for example.

Disease Classification

Condition: Tinnitus
Disease Family: Diseases of the Ear and Mastoid Process
Organ System: Nervous System
ICD-10 Chapter: Diseases of the Ear and Mastoid Process
ICD-10 Code: H93.1

Tinnitus Symptoms:

The experience of a noise or a sound without external stimulation of the auditory pathways. Intermittent sounds or chronic ones. The experience can vary greatly: some people experience hearing their own pulse, other a consistent high-pitched humming, while other may hear a loud, roaring sound. Additional symptoms may include a sense of irritation, frustration, insomnia, rumination, anxiety, or depression for instance.

Also known as:

Aurium Tinnitus, Tinnitus Aurium, Subjective Tinnitus, Objective Tinnitus, Persistent Tinnitus, Non-auditory Tinnitus, Non-vibratory Tinnitus, Pseudo Tinnitus, Vibratory Tinnitus, Pulsatile Tinnitus, Auditory Phantom Perception, Ringing in Ears

Drug Interactions

THC Interaction with Pharmaceutical Drugs

  • THC can enhance the effects of drugs that cause sedation and depress the central nervous system, such as benzodiazepines, barbiturates, and alcohol, for example. 
  • THC is metabolized by and an inhibitor of a number of enzymatic liver pathways referred to as cytochrome P450. There are more than 50 enzymes belonging to this enzyme family, a number of which are responsible for the breakdown of common drugs such as antidepressants (e.g. amitriptyline, doxepine, fluvoxamine), antipsychotics (haloperidol, clozapine, stelazine), beta-blockers (e.g. propranolol), bronchodilators (e.g. theophylline), or bloodthinners (e.g. warfarin).  Thus patients taking these classes of medication may find that THC increases the concentration and effects of these drugs as well as the duration of their effects.
  • Clinical observation suggests no likely interactions with other pharmaceuticals at a total daily dose of up to 20mg THC.

CBD Interaction with Pharmaceutical Drugs

  • CBD may alter action on metabolic enzymes (certain drug-transport mechanisms), and as such may alter interactions with other drugs, some of which may produce therapeutic or adverse effects. For instance, CBD interacts with the enzyme cytochrome P450 3A4 and cytochrome P450 2C19, increasing the bioavailability of anti-epileptic drugs such as clobazam (a benzodiazepine). This makes it possible to achieve the same results at significantly lower dosages, reducing treatment costs and risks of adverse effects. 
  • Groups of drugs affected include: anti-epileptic drugs, psychiatric drugs, and drugs affecting metabolic enzymes, for example.
  • Clinical observations suggest no likely interactions with other pharmaceuticals at a total daily dose of up to 100mg CBD

Dosing Considerations

THC Dosage Considerations

  • THC micro dose:  0.1 mg to 0.4 mg
  • THC low dose:  0.5 mg to 5 mg
  • THC medium dose:  6 mg to 20 mg
  • THC high dose:  21 mg to 50+ mg

CBD Dosage Considerations

  • CBD low dose:  0.4 mg to 19 mg
  • CBD medium dose: 20 mg to 99 mg
  • CBD high dose:  100 mg to 800+ mg (upper limits tested ~1,500mg)

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.